Connection Between Epigenome, Selective Mutability, Evolution, and Human Disease
Li, Harris et al., PLoS Genetics
Researchers at the Baylor College of Medicine and elsewhere propose a "connection between the epigenome, selective mutability, evolution, and human disease" based on the findings of their study on associations of structural mutability with germline DNA methylation and with non-allelic homologous recombination mediated by low-copy repeats. "Combined evidence from four human sperm methylome maps, human genome evolution, structural polymorphisms in the human population, and previous genomic and disease studies consistently points to a strong association of germline hypomethylation and genomic instability," the Baylor-led team writes.
23andMe, Genentech Recruiting Patients for Alzheimer's Genetics Research
June 29, 2011
"This research could lead to new scientific knowledge or possibly a drug that could prevent or slow [the] disease," 23andMe states in an informational release targeted to customers who may be eligible to participate in an Alzheimer's study it is conducting with biotech partner Genentech.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.
New to GenomeWeb? Register quickly here.
Related Stories
- Genentech Takes Personalized Medicine Approach in Pursuing Amyloid Hypothesis for Alzheimer's Drug
May 23, 2012 / Pharmacogenomics Reporter - NIH Study Finds DTC Genetic Risk Info Doesn't Increase Patients' Use of Healthcare Services
May 23, 2012 / Pharmacogenomics Reporter - 23andMe Eliminates Subscription Model
May 10, 2012 / GenomeWeb Daily News - Dako, Genentech Partner on Regulatory Submission of CDx for Second Breast Cancer Drug
May 1, 2012 / GenomeWeb Daily News - Generex to Meet with FDA about AE37 HER2 Peptide Vaccine; Companion Dx Path Still Unclear
March 7, 2012 / Pharmacogenomics Reporter